GGrantIndex
Sort

17,828 grants matching crispr

Evolutionary Conserved Mechanisms that Control Central Nervous System Development Regeneration and Degeneration

$386,000
Ayelet Voskoboynik · Stanford University · R01 · FY2024 · AG

Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity

$386,000
Ovijit Chaudhuri · Stanford University · R01 · FY2025 · GM

Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity

$386,000
Ovijit Chaudhuri · Stanford University · R01 · FY2023 · GM

Targeted aberrant signaling in CBL-mutant leukemia

$385,968
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Investigation of DUF1220 domains in human brain function and disease

$385,918
James M Sikela · University Of Colorado Denver · R01 · FY2020 · MH

Defining the molecular interactions required for flavivirus genome packaging and virus assembly

$385,887
Joyce Jose · Pennsylvania State University, The · R01 · FY2023 · AI

Elucidating CHD in Down Syndrome with Cardiac Organoids and 3D Genome Architecture

$385,799
Joseph C Wu · Stanford University · R01 · FY2023 · HL

The role of sex- and cell-type specific protein degradation increases in the amygdala in fear memory formation

$385,768
Timothy Joseph Jarome · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · MH

Reversing molecular cancer phenotypes by targeting epigenetic alterations in prostate cancer

$385,688
Suhn Kyong Rhie · University Of Southern California · R21 · FY2021 · CA

Post-transcriptional mechanisms of gene regulation in cardiac cell growth and development

$385,624
Auinash Kalsotra · University Of Illinois At Urbana-Champaign · R01 · FY2022 · HL

Post-transcriptional mechanisms of gene regulation in cardiac cell growth and development

$385,624
Auinash Kalsotra · University Of Illinois At Urbana-Champaign · R01 · FY2023 · HL

Post-transcriptional mechanisms of gene regulation in cardiac cell growth and development

$385,624
Auinash Kalsotra · University Of Illinois At Urbana-Champaign · R01 · FY2021 · HL

Innovation Grant to Nurture Initial Translational Efforts (IGNITE) to Neurotherapeutic Approaches in Minipig Models of PKU Disorders

$385,610
Robert D Nicholls · University Of Pittsburgh At Pittsburgh · R21 · FY2018 · NS

Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies

$385,609
Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Functional characterization of craniofacial enhancers at single cell and single base pair resolution

$385,605
Justin Lee Cotney · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · DE

Targeting a novel H3.3 epigenetic switch to regulate health and disease

$385,488
Paul S Knoepfler · University Of California At Davis · R01 · FY2018 · GM

CANCAN - Kaiser

$385,439
Bette J Caan · Kaiser Foundation Research Institute · OT2 · FY2022 · CA

Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation

$385,437
Boyi Gan · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation

$385,437
Boyi Gan · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Population genetics of rapid evolutionary processes

$385,356
Philipp W Messer · Cornell University · R35 · FY2025 · GM

Elucidating the origins of cortical tuber cells using human brain organoid models of TSC

$385,317
Helen S. Bateup · University Of California Berkeley · R01 · FY2022 · NS

Defining the molecular interactions required for flavivirus genome packaging and virus assembly

$385,292
Joyce Jose · Pennsylvania State University, The · R01 · FY2024 · AI

Molecular Mechanisms of Inflammasome Activation During Salmonella Infections

$385,267
Denise M. Monack · Stanford University · R01 · FY2019 · AI

Epigenome Editing Technologies for Treating Diverse Disease

$385,093
Charles A Gersbach · Duke University · U01 · FY2020 · AI

Imaging macromolecular machines in gene regulation

$385,065
David W Taylor · University Of Texas At Austin · R35 · FY2025 · GM